Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells – blocking the energy supply T cells depend on. The work points toward a promising new immunotherapy approach for ovarian cancer.

A new system can accurately assess the chromosomal status of in vitro-fertilized embryos using only time-lapse video images of the embryos and maternal age, according to a study from investigators at Weill Cornell Medicine.

Professors Dr. Silvia Formenti and Dr. Massimo Loda have been elected to the National Academy of Medicine, in recognition of outstanding professional achievement and major contributions to the advancement of the medical sciences.

A gift totaling $25 million from Irwin M. Jacobs ’54, BEE ’56 and the Jacobs family includes a new $15 million commitment, adding to a $10 million commitment in 2023 that helped establish the center.

The fireside chat was part of a two-day visit by Dr. Robert M. Califf, commissioner of the U.S. Food and Drug Administration, who focused on medicine and health care innovations.

Researchers have identified the origin of ovarian cancer that develops in the fallopian tube, which opens doors to discovering new methods for diagnosing the disease and potential therapies.

A new study emphasizes the importance of considering sex differences in Alzheimer’s research – a step that could ultimately lead to more precise and effective treatments.

The transition to menopause is marked by a progressively higher density of estrogen receptors on brain cells, a measure that remains elevated in women up to their mid-60s, according to a new brain imaging study.